TickerFacts.

TFA Therapeutics, Inc. (RAJAF): Total Assets

Annual figures by period end, from SEC filings.

$4.66M
As of 2025-12-31
+30.3%
3-year compound annual growth
+10.5%
5-year compound annual growth
2020-12-31: $2.83M2021-12-31: $3.26M2022-12-31: $2.10M2023-12-31: $3.35M2024-12-31: $4.62M2025-12-31: $4.66M$4.66M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$4.66M+0.7%2026-05-15, Balance as of period end
2024-12-31$4.62M+37.9%2026-05-15, Balance as of period end
2023-12-31$3.35M+59.2%2025-09-23, Balance as of period end
2022-12-31$2.10M-35.5%2025-09-23, Balance as of period end
2021-12-31$3.26M+15.5%2023-05-15, Balance as of period end
2020-12-31$2.83Mn/a2023-05-15, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
TFA Therapeutics, Inc. (RAJAF)2025-12-31$4.66M+0.7%
Adia Med, Inc. (ADIA)2025-12-31$594.8K-10.7%
Target Group Inc. (CBDY)2025-12-31$6.18M-18.4%
Healthy Extracts Inc. (HYEX)2025-12-31$27.82Mn/m
China Foods Holdings Ltd. (CFOO)2025-12-31$212.9K-51.1%
Nutra Pharma Corp (NPHC)2025-12-31$584.6K-2.5%
Functional Brands Inc. (MEHA)2025-12-31$9.11M+27.0%
Bon Natural Life Ltd (BON)2025-09-30$85.19M+37.9%
Charlie's Holdings, Inc. (CHUC)2025-12-31$11.56M+193.1%

Compare RAJAF, ADIA, CBDY, HYEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗